BioVie Inc (BIVI)

[someconcerns]

BD, I've spoken a couple times with management and have confidence in their being able to bring a proven drug in Europe thru to approval in the US. I'm sure, with the experienced people they have brought on board, their have the contacts and wherewithal to sell either the drug outright or get a larger pharma to buy us out. This is not a novel, untested product.

I own both publicly traded shares (from the earlier incarnation of the public company and purchased more recently as BIVI) and locked up shares purchased with warrants as part of their initial PIPE.

I think you'll find that most shares outstanding are locked up and not yet tradeable, like mine. Hence the low volume being traded. BIVI also now has an agreement with Aspire Capital, whereby BIVI management can direct Aspire to buy up to a certain limited number of shares daily.

So, what you may be seeing are a few shares from Aspire reselling into the market but not selling so many shares as to cut the legs out from under the stock. There is not a large overhang of shares to trade, thus it's hard for flippers to scare up enough shares to trade constantly.

Slow, steady accumulation is called for if you share my views.